1. Home
  2. ATNM vs AP Comparison

ATNM vs AP Comparison

Compare ATNM & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • AP
  • Stock Information
  • Founded
  • ATNM 2000
  • AP 1929
  • Country
  • ATNM United States
  • AP United States
  • Employees
  • ATNM N/A
  • AP N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • AP Fluid Controls
  • Sector
  • ATNM Health Care
  • AP Industrials
  • Exchange
  • ATNM Nasdaq
  • AP Nasdaq
  • Market Cap
  • ATNM 50.2M
  • AP 44.5M
  • IPO Year
  • ATNM N/A
  • AP N/A
  • Fundamental
  • Price
  • ATNM $1.51
  • AP $2.19
  • Analyst Decision
  • ATNM Strong Buy
  • AP
  • Analyst Count
  • ATNM 2
  • AP 0
  • Target Price
  • ATNM $4.50
  • AP N/A
  • AVG Volume (30 Days)
  • ATNM 160.4K
  • AP 57.6K
  • Earning Date
  • ATNM 11-13-2025
  • AP 11-10-2025
  • Dividend Yield
  • ATNM N/A
  • AP N/A
  • EPS Growth
  • ATNM N/A
  • AP N/A
  • EPS
  • ATNM N/A
  • AP N/A
  • Revenue
  • ATNM N/A
  • AP $414,471,000.00
  • Revenue This Year
  • ATNM N/A
  • AP N/A
  • Revenue Next Year
  • ATNM N/A
  • AP N/A
  • P/E Ratio
  • ATNM N/A
  • AP N/A
  • Revenue Growth
  • ATNM N/A
  • AP N/A
  • 52 Week Low
  • ATNM $1.03
  • AP $1.61
  • 52 Week High
  • ATNM $2.41
  • AP $3.99
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 43.91
  • AP 41.54
  • Support Level
  • ATNM $1.47
  • AP $1.91
  • Resistance Level
  • ATNM $1.59
  • AP $2.19
  • Average True Range (ATR)
  • ATNM 0.08
  • AP 0.15
  • MACD
  • ATNM -0.00
  • AP 0.02
  • Stochastic Oscillator
  • ATNM 28.95
  • AP 56.44

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: